laser treatment

FDA expands indications for SculpSureThe U.S. Food and Drug Administration granted an expanded FDA 510(k) clearance in September for Cynosure’s non-invasive body contouring product, SculpSure.
Path to cure port-wine stains
Path to cure port-wine stains80% of port-wine stains improve with laser treatment, but less than 20% clear completely. In this article, with Dr. Iris Kedar Rubin, reviews effective treatment strategies.
Lasers in melanoma careLaser for melanoma in situ (MIS) should generally be reserved for nonsurgical, usually elderly patients. When indicated, MIS may be treated with CO2 laser or with combined Q-switched Nd:YAG and imiquimod. Any atypical-appearing lesion should be biopsied prior to the start of a laser treatment.
Periocular complications require timely managementExpert advises preparing for complications to act fast and follow up early and often. Read more tips. retinal treatment results take center stage in 2015Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
The Ethics of Pricing MD vs RN TreatmentsIs it ethical to have a non-physician deliver laser/light treatment to patients at the same price? David Goldberg, M.D., J.D., and A. Jay Burns, M.D., call this topic into question at the Laser Roundtable during Vegas Cosmetic Surgery 2014.
FDA clears PicoSure for wrinkle treatmentThe Food and Drug Administration has granted 510(k) clearance to Cynosure, allowing it to market its PicoSure laser workstation for the treatment of wrinkles.
Study spots small differences in varicose vein treatmentsA new study suggests that three common treatments for varicose veins are similarly effective in easing symptoms — but that small quality-of-life differences may be felt months after symptom appear.
Nonablative laser improves appearance of old scarsA nonablative fractional laser improves the appearance of mature burn scars, according to results of a recent study.
Delayed or immediate laser treatment for DME yield similar resultsAccording to research recently presented at the American Society of Retina Specialists annual meeting, focal or grid laser treatment that coincides with the initiation of intravitreal ranibizumab for the treatment of diabetic macular edema (DME) shows results no better than when laser treatment is deferred for 24 weeks or more.